Health & Fitness
Health and Fitness
Health and Fitness
Mon, October 24, 2011
Sat, October 22, 2011
Fri, October 21, 2011
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011 -- MISSISSAUGA, Ontario, Oct. 21, 2011 /PRNewswire/ --
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
MISSISSAUGA, Ontario, Oct. 21, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ]) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, November 3, 2011 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the 2011 third quarter.
The dial-in number to participate on this call is (877) 295-5743, confirmation code18668216. International callers should dial (973) 200-3961, confirmation code 18668216. A replay will be available approximately two hours following the conclusion of the conference call to Thursday, November 10, 2011, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 18668216.
The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at [ www.valeant.com ]. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at [ www.valeant.com ].
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at [ www.valeant.com ].
Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]
(Logo: [ http://photos.prnewswire.com/prnh/20101025/LA87217LOGO ])
SOURCE Valeant Pharmaceuticals International, Inc.
[ Back to top ] RELATED LINKS
[ http://www.valeant.com ]
